AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a treatment forpatients suffering from specific type of endometrial cancer.
The Walt Disney Company (NYSE: DIS) is officially back on track with its newest animation hit, Inside Out 2. For its debut weekend, Disney’s newest theatrical release sold almost $300 million in total ticket sales across the globe, easing concerns that its storytelling magic is gone.
Tesla Inc (NASDAQ: TSLA) got the lead on the EV front as a pioneer with Elon Musk’s visionary leadership. But regulatory challenges, competition and an unfavorable macroeconomic environment made the ambitious Tesla focus on making an affordable vehicle while autonomous driving remains work in progress.
On Thursday, Adobe Inc (NASDAQ: ADBE) topped expectations on earnings and revenue with its fiscal second quarter results, along with lifting the full-year guidance.
With the EV adoption in the U.S. being slower than anticipated, General Motors (NYSE: GM) revised this year’s expected EV sales and production, while being launching its newest EVs, including its new entry-level Chevrolet Equinox EV.
On Tuesday, Oracle Corporation (NYSE: ORCL) posted its fiscal fourth-quarter earnings that were below estimates. But, known for its database software, Oracle went all in to expand its cloud infrastructure unit to compete with Amazon.com Inc (NASDAQ:
On Friday, GameStop Corporation (NYSE: GME) failed to show signs of an operational turnaround as it delivered its fiscal first quarter results earlier than expected, previously saying they will be issued on June 11thafter market close.
On Thursday, Nio Inc (NYSE: NIO) issued its unaudited first fiscal quarter results that showed its financials were hurt by promotional activity and the price war Tesla Inc (NASDAQ: TSLA) ignited, as loss widened despite improved margins.